1993
DOI: 10.1016/0278-6915(93)90225-n
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic peroxisome proliferation in rodents and its significance for humans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
143
0
1

Year Published

1996
1996
2016
2016

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 253 publications
(149 citation statements)
references
References 186 publications
4
143
0
1
Order By: Relevance
“…33,34 In conclusion, peroxisome proliferators upregulate L-FABP expression through activation of peroxisome proliferator activated receptors. 35 Peroxisome proliferators also increase intracellular levels of peroxisomes, 36 resulting in an overproduction of hydrogen peroxide. 37,38 Hydrogen peroxide, being a precursor of ROS, may contribute to the hepatocarcinogenic effects of peroxisome proliferators.…”
Section: Discussionmentioning
confidence: 99%
“…33,34 In conclusion, peroxisome proliferators upregulate L-FABP expression through activation of peroxisome proliferator activated receptors. 35 Peroxisome proliferators also increase intracellular levels of peroxisomes, 36 resulting in an overproduction of hydrogen peroxide. 37,38 Hydrogen peroxide, being a precursor of ROS, may contribute to the hepatocarcinogenic effects of peroxisome proliferators.…”
Section: Discussionmentioning
confidence: 99%
“…Using 3 hepatocarcinogens, 2-AAF, 3'-Me-DAB, and DL-ethionine, at 3 dose levels, it was clearly indicated that the degree of induction of GST-P-positive foci and nodules in the medium-term bioassay system corresponds with the incidences of hepatocellular carcinomas as revealed by longterm carcinogen exposure (35). A precise dose-response study was also performed using 2-AAF as a model compound to compare the results with the EDO, mega-mouse study of hepatocarcinogenicity (44), and the reliability of our system was again confirmed (51 4 carcinogenic peroxisome proliferators, and tamoxifen did not enhance development of GST-P-positive foci development. With regard to the carcinogenicity of nonmutagenic peroxisome proliferators, it is important to remember that they depress GST-P expression, and the lesions associated with their hepato- (Table III).…”
Section: Marker Lesionsmentioning
confidence: 91%
“…This contrasts with the effects of peroxisome proliferators and high doses of certain complex vegetable and animal oils (7,17). This difference together with the absence of visual lipid accumulation in the liver of mice fed the Lorenzo's Oil-supplemented diets may indirectly suggest that the hepatic peroxisomal ␤-oxidation capacity in treated mice was not overloaded by the excess of erucic and oleic acids.…”
Section: Discussionmentioning
confidence: 97%